Affymax downgraded to Neutral from Outperform at RW Baird

theflyonthewall.com

RW Baird downgraded Affymax following the recall of Omontys and lowered its price target for shares to $4 from $30. Note Affymax shares were also downgraded this morning at Piper Jaffray.

View Comments (0)